Article Text

PDF
89 IMPLANTATION OF A FIBROBLAST PATCH IMPROVES LEFT VENTRICULAR SYSTOLIC FUNCTION AND PREVENTS REMODELING AFTER MYOCARDIAL INFARCTION.
  1. H. Thai,
  2. E. Juneman,
  3. L. Castellano,
  4. R. Do,
  5. M. Gaballa,
  6. S. Goldman
  1. Section of Cardiology, Department of Medicine, SAVAHCS and the Sarver Heart Center, University of Arizona, Tucson, AZ

Abstract

Background Tissue engineering is a novel method to restore myocardial function in ischemic heart disease. One technique is to apply a biologically active graft onto the infarcted region (IR) of the left ventricle (LV). The effects of a fibroblast patch (3DFC) placement on the IR of the LV on systolic/diastolic function in a coronary artery ligation (CAL) model of heart failure were evaluated.

Methods CAL to induce myocardial infarction (MI) is performed on Sprague-Dawley rats. The 3DFC patch is placed on the IR. Echos were done at 3 weeks. Hemodynamics was measured. LV regional systolic displacement (SD), LV ejection fraction (LVEF), LV fractional shortening (FS), and LV pressure/diameter relaxation curves were obtained.

Results 3DFC patch placement improved (p < .05) LV SD, LVEF, and LVFS in MI animals. The LV diastolic relaxation slope and the LV diameter of the MI animals that received a patch are comparable to the sham rats.

Summary Implantation of a fibroblast mesh on the IR of the LV improved LV systolic function. The patch also prevented LV dilation and normalized LV diastolic function post MI. Our data illustrate the future potential of using a biologically active graft in the treatment of ischemic heart failure.

Statistics from Altmetric.com

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.